| 000 | 01599 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250510211220.0 | ||
| 264 | 0 | _c19790629 | |
| 008 | 197906s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(79)91077-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSpiegel, R J | |
| 245 | 0 | 0 |
_aAdrenal suppression after short-term corticosteroid therapy. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cMar 1979 |
||
| 300 |
_a630-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdrenal Cortex Function Tests |
| 650 | 0 | 4 |
_aAdrenal Glands _xdrug effects |
| 650 | 0 | 4 |
_aAdrenal Insufficiency _xchemically induced |
| 650 | 0 | 4 | _aAdrenocorticotropic Hormone |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDepression, Chemical |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHodgkin Disease _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 |
_aLeukemia, Lymphoid _xdrug therapy |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aVigersky, R A | |
| 700 | 1 | _aOliff, A I | |
| 700 | 1 | _aEchelberger, C K | |
| 700 | 1 | _aBruton, J | |
| 700 | 1 | _aPoplack, D G | |
| 773 | 0 |
_tLancet (London, England) _gvol. 1 _gno. 8117 _gp. 630-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(79)91077-8 _zAvailable from publisher's website |
| 999 |
_c83883 _d83883 |
||